Takuma Y - Search Results

1

Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma.

Hanafusa T, Yumoto Y, Nouso K, Nakatsukasa H, Onishi T, Fujikawa T, Taniyama M, Nakamura S, Uemura M, Takuma Y, Yumoto E, Higashi T, Tsuji T. Hanafusa T, et al. Among authors: takuma y. Cancer Lett. 2002 Feb 25;176(2):149-58. doi: 10.1016/s0304-3835(01)00736-4. Cancer Lett. 2002. PMID: 11804742

2

Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma.

Matsumoto E, Nakatsukasa H, Nouso K, Kobayashi Y, Nakamura S, Suzuki M, Takuma Y, Tanaka H, Fujikawa T, Shiratori Y. Matsumoto E, et al. Among authors: takuma y. Liver Int. 2004 Aug;24(4):379-83. doi: 10.1111/j.1478-3231.2004.0923.x. Liver Int. 2004. PMID: 15287862

3

Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.

Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T, Shiratori Y. Takuma Y, et al. J Gastroenterol Hepatol. 2004 Nov;19(11):1300-4. doi: 10.1111/j.1440-1746.2004.03447.x. J Gastroenterol Hepatol. 2004. PMID: 15482538

4

IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.

Yumoto E, Nakatsukasa H, Hanafusa T, Yumoto Y, Nouso K, Matsumoto E, Onishi T, Takuma Y, Tanaka H, Fujikawa T, Suzuki M, Uemura M, Shiratori Y. Yumoto E, et al. Among authors: takuma y. Int J Oncol. 2005 Nov;27(5):1223-30. Int J Oncol. 2005. PMID: 16211216

5

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review.

Takuma Y, Nouso K. Takuma Y, et al. World J Gastroenterol. 2010 Mar 28;16(12):1436-41. doi: 10.3748/wjg.v16.i12.1436. World J Gastroenterol. 2010. PMID: 20333782 Free PMC article. Review.

6

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma.

Miyahara K, Nouso K, Morimoto Y, Takeuchi Y, Hagihara H, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Honda M, Kaneko S, Sato T, Sato S, Obi S, Iwadou S, Kobayashi Y, Takaguchi K, Kariyama K, Takuma Y, Takabatake H, Yamamoto K; Okayama Liver Cancer Group. Miyahara K, et al. Among authors: takuma y. Br J Cancer. 2013 Oct 15;109(8):2072-8. doi: 10.1038/bjc.2013.554. Epub 2013 Sep 17. Br J Cancer. 2013. PMID: 24045661 Free PMC article.

7

Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma.

Miyahara K, Nouso K, Morimoto Y, Takeuchi Y, Hagihara H, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Iwadou S, Kobayashi Y, Takaguchi K, Takuma Y, Takabatake H, Sakaguchi K, Yamamoto K; Okayama Liver Cancer Group. Miyahara K, et al. Among authors: takuma y. Hepatol Res. 2014 Mar;44(3):296-301. doi: 10.1111/hepr.12123. Epub 2013 Apr 29. Hepatol Res. 2014. PMID: 23607549

8

Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma.

Takuma Y, Nouso K, Makino Y, Saito S, Takayama H, Takahara M, Takahashi H, Murakami I, Takeuchi H. Takuma Y, et al. Liver Int. 2007 Jun;27(5):620-6. doi: 10.1111/j.1478-3231.2007.01462.x. Liver Int. 2007. PMID: 17498246

9

Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.

Takuma Y, Nouso K, Makino Y, Gotoh T, Toshikuni N, Morimoto Y, Shimomura H, Yamamoto H. Takuma Y, et al. J Gastroenterol Hepatol. 2011 Sep;26(9):1417-24. doi: 10.1111/j.1440-1746.2011.06775.x. J Gastroenterol Hepatol. 2011. PMID: 21884248

10

Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.

Adachi T, Nouso K, Miyahara K, Oyama A, Wada N, Dohi C, Takeuchi Y, Yasunaka T, Onishi H, Ikeda F, Nakamura S, Shiraha H, Takaki A, Takabatake H, Fujioka SI, Kobashi H, Takuma Y, Iwadou S, Uematsu S, Takaguchi K, Hagihara H, Okada H; Okayama Liver Cancer Group. Adachi T, et al. Among authors: takuma y. J Gastroenterol Hepatol. 2019 Jun;34(6):1081-1087. doi: 10.1111/jgh.14535. Epub 2018 Dec 10. J Gastroenterol Hepatol. 2019. PMID: 30402928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page